MJIC Inc., a pot distributor building a “cannabis superhighway” in California, is planning a Canadian listing by the end of February.

The company, based in Commerce, near Los Angeles, plans to sell shares on the Canadian Securities Exchange via a reverse takeover, Chief Executive Officer Sturges Karban said in a phone interview. MJIC has hired Haywood Securities Inc. to identify a Canadian shell company to enable the deal.

“Our timeline to get through to that point is probably another 30 to 45 days or so,” he said. Karban declined to say how much MJIC expects to raise but said the listing would be followed by a “much broader, bigger offering.”

Acreage Holdings and Organigram are some of the few cannabis companies to release 2019 revenue guidance. Given the early stage of the cannabis industry, companies often do not provide revenue & EBITDA outlooks, likely due to speculation. The cannabis stocks on our list have provided revenue estimates for 2019, which give investors and analysts an expectation to follow.

Shoppers Drug Mart's e-commerce platform for medical cannabis launched Tuesday, a month after Health Canada licenced the company to sell the product online.

Product information is available nationally, but Shoppers Drug Mart can initially only sell medical cannabis to patients in Ontario. Patients will be required to take a medical document similar to a prescription to an Ontario pharmacy to begin the process. Specialized advisers will then contact patients, review their medical history and provide support with online registration and product selection.

Shoppers Drug Mart says it has signed supply agreements with 10 licensed producers of dried cannabis and cannabis oil and will provide products and medical accessories.

If any investors had been wondering how long it would take for the marijuana industry to shed its moniker as "taboo" and become a legitimate business model, wonder no longer.

Last year was a game changer in many ways for the cannabis industry. Canada became the first industrialized country to legalize adult-use weed, the U.S. Food and Drug Administration approved its first cannabis-derived drug, and President Trump signed the Farm Bill into law, legalizing hemp and hemp-based cannabidiol (CBD). Any doubts about marijuana being a valid business model were tossed out the window.

Headset, an analytics startup for the nascent marijuana industry, closed a $12.1 million Series A funding round backed by prominent investors.

The round was led by Poseidon Asset Management, an early Juul investor that's raising a $75 million venture fund to go after marijuana startups, and included middle-market private-equity fund AFI Capital Partners and Canopy Rivers, the venture arm of the publicly traded marijuana cultivator Canopy Growth.

Canopy Growth Corp  (TSX:WEED)(NYSE:CGC) is Canada’s best-known marijuana stock. But in terms of financial results, it’s been far from the best performer. While competitors like Aurora Cannabis Inc have it beat on growth, others, such as CannTrust Holdings have achieved operating profits faster. Nevertheless, Canopy is still the #1 cannabis stock in terms of pure revenue: its sales surpassed Aurora’s by over $20,000,000 in its most recent quarter.

Marijuana stocks have ebbed and flowed for a few years now, but the absolute peak of the frenzy hit about this time last year. That made the prospect of a year-end list a tough proposition. How bad was it? Of the scores of cannabis related issuers listed in Canada just eight had a positive return in 2018.

You heard that right. Eight.

The culprit, of course, was a year end swoon in global markets that wreaked havoc on most every sector and gutted this one.

A survey taken in early October, for instance, would have produced dozens of winners. But that, as they say, is why you play until the final buzzer. We bring you the top ten Canadian-listed marijuana stocks of 2018.

CannTrust Holdings Inc. CNTTF, +3.04% said Tuesday that it has applied to list its shares on the New York Stock Exchange, following other large Canadian cannabis companies that list in the U.S. but operate in Canada.

CannTrust stock was down 4% in morning trading, as the ETFMG Alternative Harvest ETF MJ, -0.14% fell 1.8%.

"CannTrust has firmly established itself as one of the top licensed producers in Canada with a global platform rooted in trust, science and innovation," CannTrust Chief Executive Peter Aceto said in a statement.

While recreational marijuana has been legal in Canada since October 2018, some companies have been left in limbo as they wait for regulations on cannabis edibles, topicals and extracts.

However, that's expected to change later this year.

Once Health Canada finalizes its proposal on regulations, such cannabis products will be permitted for sale under The Cannabis Act no later than October 17, 2019.

Aurora Cannabis Inc. says it expects to report second-quarter revenue of between $50 million and $55 million.

Analysts had expected revenue at the marijuana producer to total about $67 million for the quarter ended Dec. 31, 2018, according to Thomson Reuters Eikon.

Aurora says the result for the quarter is up from $11.7 million in the same quarter a year ago and better than the $29.7 million for the quarter ended Sept. 30.

The increase was driven by the start of the adult consumer use market in Canada in October and shipments of medical cannabis to Aurora's base of roughly 71,000 patients in Canada.

The company says its production capacity is now about 100,000 kilograms per year, up from 70,000 in November.